Have a personal or library account? Click to login
Growth pattern and pubertal development in patients with classic 21-hydroxylase deficiency Cover

Growth pattern and pubertal development in patients with classic 21-hydroxylase deficiency

Open Access
|Feb 2017

References

  1. 1. Speiser PW, White PC. Congenital adrenal hyperplasia. N Engl J Med. 2003; 349:776-88.10.1056/NEJMra021561
  2. 2. Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine clinical practice guideline. J Clin Endocrinol Metab. 2010; 95:4133-60.10.1210/jc.2009-2631
  3. 3. Soliman AT, AlLamki M, AlSalmi I, Asfour M. Congenital adrenal hyperplasia complicated by central precocious puberty: linear growth during infancy and treatment with gonadotropin-releasing hormone analog. Metabolism. 1997; 46:513-7.10.1016/S0026-0495(97)90186-4
  4. 4. Muirhead S, Sellers EA, Guyda H. Indicators of adult height outcome in classical 21-hydroxylase deficiency congenital adrenal hyperplasia. J Pediatr. 2002; 141: 247-52.10.1067/mpd.2002.12660112183722
  5. 5. Eugster EA, Dimeglio LA, Wright JC, Freidenberg GR, Seshadri R, Pescovitz OH. Height outcome in congenital adrenal hyperplasia caused by 21- hydroxylase deficiency: a meta-analysis. J Pediatr. 2001; 138:26-3210.1067/mpd.2001.11052711148508
  6. 6. Bonfig W, Bechtold S, Schmidt H, Knorr D, Schwarz HP. Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty. J Clin Endocrinol Metab. 2007; 92:1635-910.1210/jc.2006-210917299071
  7. 7. Trinh L, Nimkarn S, New MI, Lin-Su K. Growth and pubertal characteristics in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Pediatr Endocrinol Metab. 2007; 20:883-91
  8. 8. Muthusamy K, Elamin MB, Smushkin G, Murad MH, Lampropulos JF, Elamin KB, et al. Clinical review: Adult height in patients with congenital adrenal hyperplasia: a systematic review and metaanalysis. J Clin Endocrinol Metab. 2010; 95:4161-72.10.1210/jc.2009-261620823467
  9. 9. Somboonnithiphol K, Panamonta O, Kiatchoosakun P, Jirapradittha J, Panamonta M, Lumbiganon P, et al. Newborn screening for congenital adrenal hyperplasia in Srinagarind Hospital, Khon Kaen University, Thailand. Asian Biomed. 2011; 5:855-9.
  10. 10. Wacharasindhu S, Supornsilchai V, Aroonparkmongkol S, Sahakitrungrueng T. Pubertal growth in normal Thai children: a longitudinal study. Asian Biomed. 2010; 4:793-5.10.2478/abm-2010-0103
  11. 11. Manoli I, Kanaka-Gantenbein CH, Voutetakis A, Maniati-Christidi M, Dacou-Voutetakis C. Early growth, pubertal development, body mass index and final height of patients with congenital adrenal hyperplasia: factors influencing the outcome. Clinical Endocrinology. 2002; 57:669-76.10.1046/j.1365-2265.2002.01645.x12390343
  12. 12. Janejai N, Krasao P, Phansang J, Pankarnjanato R, Charoensiriwatana W. Congenital adrenal hyperplasia: should nationwide screening be implemented in Thailand? Southeast Asian J Trop Med Public Health. 2003; 34 Suppl 3:170-3.
  13. 13. Bonfig W, Pozza SB, Schmidt H, Pagel P, Knorr D, Schwarz HP. Hydrocortisone dosing during puberty in patients with classical congenital adrenal hyperplasia: an evidence-based recommendation. J Clin Endocrinol Metab. 2009; 94:3882-8.10.1210/jc.2009-094219622620
  14. 14. Mikhail G. Hormone secretion by the human ovaries. Gynecol Invest. 1970; 1:5-20.10.1159/000301902
  15. 15. Miller WL, Auchus RJ. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev. 2011; 32:81-151.10.1210/er.2010-0013
  16. 16. Scholler R, Nahoul K, Castanier M, Rotman J, Salat- Baroux J. Testicular secretion of conjugated and unconjugated steroids in normal adults and in patients with varicocele. Baseline levels and timecourse response to hCG administration. J Steroid Biochem. 1984; 20:203-15.10.1016/0022-4731(84)90207-3
  17. 17. Völkl TM, Simm D, Beier C, Dörr HG. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics. 2006; 117:e98-105.10.1542/peds.2005-100516396852
  18. 18. Finkielstain GP, Kim MS, Sinaii N, Nishitani M, Van Ryzin C, Hill SC, et al. Clinical Characteristics of a Cohort of 244 Patients with Congenital Adrenal Hyperplasia. J Clin Endocrinol Metab. 2012; 97: 4429-38.10.1210/jc.2012-2102351354222990093
  19. 19. Lin-Su K, Vogiatzi MG, Marshall I, Harbison MD, Macapagal MC, Betensky B, et al. Treatment with growth hormone and luteinizing hormone releasing hormone analog improves final adult height in children with congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2005; 90:3318-25.10.1210/jc.2004-212815797962
  20. 20. Longui CA, Kochi C, Calliari LE, Modkovski MB, Soares M, Alves EF, et al. Near-final height in patients with congenital adrenal hyperplasia treated with combined therapy using GH and GnRHa. Arq Bras Endocrinol Metabol. 2011; 55:661-4.10.1590/S0004-2730201100080002322218451
DOI: https://doi.org/10.5372/1905-7415.0706.241 | Journal eISSN: 1875-855X | Journal ISSN: 1905-7415
Language: English
Page range: 787 - 794
Published on: Feb 4, 2017
Published by: Chulalongkorn University
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year

© 2017 Supawadee Bunraungsak, Tippayakarn Klomchan, Taninee Sahakitrungruang, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.